$88.24
+19.26 (+27.92%)
TMDX News2 articles
TransMedics Reaffirms Revenue Target Amid CFO Transition; Margin Concerns Linger
TransMedics reiterates its 2026 revenue forecast while naming a new CFO, but margin compression in Q2 raises questions about operating leverage.
TransMedics Shares Slide 23% on Earnings Miss, Despite Revenue Growth
TransMedics shares plunged 23% after Q1 adjusted earnings of $0.30 missed estimates, despite a 21% revenue increase. Profit fell sharply as costs rose.